Late pharmacologic conditioning with volatile anesthetics after cardiac surgery

Critical Care

Volumn 16, Issue 5, 2012, Pages

  Steurer, Marc P ^a,b,c   Steurer, Martina A ^a,b,d   Baulig, Werner ^a   Piegeler, Tobias ^a,b,e   Schläpfer, Martin ^a,b   Spahn, Donat R ^a   Falk, Volkmar ^a   Dreessen, Pamela ^a   Theusinger, Oliver M ^a   Schmid, Edith R ^a   Schwartz, David ^e   Neff, Thomas A ^f   Beck Schimmer, Beatrice ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f Kantonsspital Muensterlingen   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; MYOGLOBIN; PROPOFOL; SEVOFLURANE; TROPONIN T; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE INJURY; HEART SURGERY; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LUNG COMPLICATION; MAJOR CLINICAL STUDY; MALE; OXYGENATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; THERAPY DELAY; ADVERSE EFFECTS; AGED; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDY;

AGED; ANESTHETICS, INHALATION; CARDIAC SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; METHYL ETHERS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPOFOL; PROSPECTIVE STUDIES;

EID: 84867302249     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11676     Document Type: Article

References (40)

1. Riedel BJ, Grattan A, Martin CB, Gal J, Shaw AD, Royston D. Long-term outcome of patients with perioperative myocardial infarction as diagnosed by troponin i after routine surgical coronary artery revascularization. J Cardiothorac Vasc Anesth 2006, 20:781-787. 10.1053/j.jvca.2006.01.015, 17138080.
2. Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T, Haverich A, Schlag G, Borst HG. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996, 61:1714-1720. 10.1016/0003-4975(96)00055-0, 8651772.
3. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997, 112:676-692. 10.1378/chest.112.3.676, 9315800.
4. Grover FL. The Society of Thoracic Surgeons National Database: current status and future directions. Ann Thorac Surg 1999, 68:367-373. discussion 374-366, 10.1016/S0003-4975(99)00599-8, 10475399.
5. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003, 75:S715-S720. 10.1016/S0003-4975(02)04701-X, 12607717.
6. Meiser A, Laubenthal H. Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Pract Res Clin Anaesthesiol 2005, 19:523-538. 10.1016/j.bpa.2005.02.006, 16013698.
7. Kong KL, Willatts SM, Prys-Roberts C. Isoflurane compared with midazolam for sedation in the intensive care unit. BMJ 1989, 298:1277-1280. 10.1136/bmj.298.6683.1277, 1836531, 2500195.
8. Meiser A, Sirtl C, Bellgardt M, Lohmann S, Garthoff A, Kaiser J, Hugler P, Laubenthal HJ. Desflurane compared with propofol for postoperative sedation in the intensive care unit. Br J Anaesth 2003, 90:273-280. 10.1093/bja/aeg059, 12594136.
9. Rohm KD, Wolf MW, Schollhorn T, Schellhaass A, Boldt J, Piper SN. Short-term sevoflurane sedation using the Anaesthetic Conserving Device after cardiothoracic surgery. Intensive Care Med 2008, 34:1683-1689. 10.1007/s00134-008-1157-x, 18500419.
10. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999, 100(19 Suppl):II340-II344.
11. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, ten Broecke PW, De Blier IG, Stockman BA, Rodrigus IE. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004, 101:299-310. 10.1097/00000542-200408000-00009, 15277911.
12. Guarracino F, Landoni G, Tritapepe L, Pompei F, Leoni A, Aletti G, Scandroglio AM, Maselli D, De Luca M, Marchetti C, Crescenzi G, Zangrillo A. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vasc Anesth 2006, 20:477-483. 10.1053/j.jvca.2006.05.012, 16884976.
13. Tritapepe L, Landoni G, Guarracino F, Pompei F, Crivellari M, Maselli D, De Luca M, Fochi O, D'Avolio S, Bignami E, Calabro MG, Zangrillo A. Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol 2007, 24:323-331. 10.1017/S0265021506001931, 17156509.
14. Melloni C. Anesthesia and sedation outside the operating room: how to prevent risk and maintain good quality. Curr Opin Anaesthesiol 2007, 20:513-519. 10.1097/ACO.0b013e3282f06ba6, 17989542.
15. Marcos-Vidal JM, Gonzalez R, Garcia C, Soria C. Out-of-operating room anesthesia: use of the AnaConDa vaporizer with anesthesia. J Clin Anesth 2012, 24:346-347. 10.1016/j.jclinane.2011.05.008, 22608592.
16. Mapleson WW. Effect of age on MAC in humans: a meta-analysis. Br J Anaesth 1996, 76:179-185. 10.1093/bja/76.2.179, 8777094.
17. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis 2009, 204:334-341. 10.1016/j.atherosclerosis.2008.10.029, 19081095.
18. Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning and translational aspects of protective measures. Am J Physiol Heart Circ Physiol 2011,
19. De Hert SG, ten Broecke PW, Mertens E, Van Sommeren EW, De Blier IG, Stockman BA, Rodrigus IE. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002, 97:42-49. 10.1097/00000542-200207000-00007, 12131102.
20. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 2003, 98:1315-1327. 10.1097/00000542-200306000-00004, 12766638.
21. Landoni G, Biondi-Zoccai GG, Zangrillo A, Bignami E, D'Avolio S, Marchetti C, Calabro MG, Fochi O, Guarracino F, Tritapepe L, De Hert S, Torry G. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007, 21:502-511. 10.1053/j.jvca.2007.02.013, 17678775.
22. Zaugg M, Schaub MC. Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning. J Muscle Res Cell Motil 2003, 24:219-249. 10.1023/A:1026021430091, 14609033.
23. Pagel PS. Postconditioning by volatile anesthetics: salvaging ischemic myocardium at reperfusion by activation of prosurvival signaling. J Cardiothorac Vasc Anesth 2008, 22:753-765. 10.1053/j.jvca.2008.03.005, 18922439.
24. Cromheecke S, Pepermans V, Hendrickx E, Lorsomradee S, Ten Broecke PW, Stockman BA, Rodrigus IE, De Hert SG. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg 2006, 103:289-296. 10.1213/01.ane.0000226097.22384.f4, 16861404.
25. Landoni G, Calabro MG, Marchetti C, Bignami E, Scandroglio AM, Dedola E, De Luca M, Tritapepe L, Crescenzi G, Zangrillo A. Desflurane versus propofol in patients undergoing mitral valve surgery. J Cardiothorac Vasc Anesth 2007, 21:672-677. 10.1053/j.jvca.2006.11.017, 17905272.
26. Bignami F, Pilotti E, Bertoncelli L, Ronzi P, Gulli M, Marmiroli N, Magnani G, Pinti M, Lopalco L, Mussini C, Ruotolo R, Galli M, Cossarizza A, Carsoli C. Stable changes in CD4+ T-lymphocyte microRNA expression following exposure to HIV-1. Blood 2012,
27. Pravdic D, Mio Y, Sedlic F, Pratt PF, Warltier DC, Bosnjak ZJ, Bienengraeber M. Isoflurane protects cardiomyocytes and mitochondria by immediate and cytosol-independent action at reperfusion. Br J Pharmacol 2010, 160:220-232. 10.1111/j.1476-5381.2010.00698.x, 2874845, 20423337.
28. Fang NX, Yao YT, Shi CX, Li LH. Attenuation of ischemia-reperfusion injury by sevoflurane postconditioning involves protein kinase B and glycogen synthase kinase 3 beta activation in isolated rat hearts. Mol Biol Rep 2010, 37:3763-3769. 10.1007/s11033-010-0030-5, 20217242.
29. Hellstrom J, Owall A, Bergstrom J, Sackey PV. Cardiac outcome after sevoflurane versus propofol sedation following coronary bypass surgery: a pilot study. Acta Anaesthesiol Scand 2011, 55:460-467. 10.1111/j.1399-6576.2011.02405.x, 21342154.
30. De Hert SG. Cardioprotection by volatile anesthetics: what about noncardiac surgery?. J Cardiothorac Vasc Anesth 2011, 25:899-901. 10.1053/j.jvca.2011.08.004, 21955826.
31. Zangrillo A, Testa V, Aldrovandi V, Tuoro A, Casiraghi G, Cavenago F, Messina M, Bignami E, Landoni G. Volatile agents for cardiac protection in noncardiac surgery: a randomized controlled study. J Cardiothorac Vasc Anesth 2011, 25:902-907. 10.1053/j.jvca.2011.06.016, 21872490.
32. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007, 50:e159-e241. 10.1016/j.jacc.2007.09.003, 17950140.
33. Landoni G, Fochi O, Zangrillo A. Cardioprotection by volatile anesthetics in noncardiac surgery? No, not yet at least. J Am Coll Cardiol 2008, 51:1321-1322. 1321; author reply.
34. Januzzi JL, Lewandrowski K, MacGillivray TE, Newell JB, Kathiresan S, Servoss SJ, Lee-Lewandrowski E. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol 2002, 39:1518-1523. 10.1016/S0735-1097(02)01789-8, 11985917.
35. Taniguchi T, Yamamoto K, Ohmoto N, Ohta K, Kobayashi T. Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med 2000, 28:1101-1106. 10.1097/00003246-200004000-00032, 10809290.
36. Taniguchi T, Kanakura H, Yamamoto K. Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med 2002, 30:904-907. 10.1097/00003246-200204000-00032, 11940767.
37. Marik PE. Propofol: an immunomodulating agent. Pharmacotherapy 2005, 25(5 Pt 2):28S-33S.
38. Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M, Jochum W, Spahn DR, Graf R, Clavien PA. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008, 248:909-918. 10.1097/SLA.0b013e31818f3dda, 19092335.
39. Langbein T, Sonntag H, Trapp D, Hoffmann A, Malms W, Roth EP, Mors V, Zellner R. Volatile anaesthetics and the atmosphere: atmospheric lifetimes and atmospheric effects of halothane, enflurane, isoflurane, desflurane and sevoflurane. Br J Anaesth 1999, 82:66-73. 10.1093/bja/82.1.66, 10325839.
40. Ryan SM, Nielsen CJ. Global warming potential of inhaled anesthetics: application to clinical use. Anesth Analg 2010, 111:92-98.